TY - JOUR
T1 - Aqueous penetration of moxifloxacin 0.5% ophthalmic solution and besifloxacin 0.6% ophthalmic suspension in cataract surgery patients
AU - Yoshida, Junko
AU - Kim, Alisa
AU - Pratzer, Kimberly A.
AU - Stark, Walter J.
N1 - Funding Information:
Supported in part from an unrestricted research grant from Alcon Laboratories to Johns Hopkins University School of Medicine, Baltimore .
Copyright:
Copyright 2010 Elsevier B.V., All rights reserved.
PY - 2010/9
Y1 - 2010/9
N2 - Purpose: To determine the aqueous humor concentrations of moxifloxacin and besifloxacin after routine preoperative topical dosing in patients having cataract surgery. Setting: Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, USA. Methods: In this prospective randomized parallel double-masked clinical trial, 1 drop of commercially available moxifloxacin 0.5% ophthalmic solution or besifloxacin 0.6% ophthalmic suspension was administered every 10 minutes for a total of 4 doses beginning 1 hour before routine cataract surgery. Aqueous humor was sampled via the paracentesis, and antibiotic concentrations were determined using validated high-performance liquid chromatography procedures. Results: The study enrolled 50 patients. The aqueous concentration of the antibiotic agent was detectable in all 23 moxifloxacin samples and in 10 (40%) of the 25 besifloxacin samples (P<.0001, Pearson chi-square test). The mean aqueous concentration in the moxifloxacin samples was 50-fold higher than in the besifloxacin samples (1.6108 μg/mL versus 0.0319 μg/mL) when all samples were included (P<.0001, Wilcoxon test), while the moxifloxacin concentration was 38-fold higher than the besifloxacin concentration (1.6108 μg/mL versus 0.0422 μg/mL) in the samples with detectable antibiotic agent (P<.0001). Conclusions: After topical preoperative administration, moxifloxacin 0.5% ophthalmic solution had a 38-fold to 50-fold higher concentration in the aqueous humor than besifloxacin 0.6% ophthalmic suspension. Besifloxacin was undetectable in more than half the aqueous humor samples. Financial Disclosure: No author has a financial or proprietary interest in any material or method mentioned.
AB - Purpose: To determine the aqueous humor concentrations of moxifloxacin and besifloxacin after routine preoperative topical dosing in patients having cataract surgery. Setting: Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, USA. Methods: In this prospective randomized parallel double-masked clinical trial, 1 drop of commercially available moxifloxacin 0.5% ophthalmic solution or besifloxacin 0.6% ophthalmic suspension was administered every 10 minutes for a total of 4 doses beginning 1 hour before routine cataract surgery. Aqueous humor was sampled via the paracentesis, and antibiotic concentrations were determined using validated high-performance liquid chromatography procedures. Results: The study enrolled 50 patients. The aqueous concentration of the antibiotic agent was detectable in all 23 moxifloxacin samples and in 10 (40%) of the 25 besifloxacin samples (P<.0001, Pearson chi-square test). The mean aqueous concentration in the moxifloxacin samples was 50-fold higher than in the besifloxacin samples (1.6108 μg/mL versus 0.0319 μg/mL) when all samples were included (P<.0001, Wilcoxon test), while the moxifloxacin concentration was 38-fold higher than the besifloxacin concentration (1.6108 μg/mL versus 0.0422 μg/mL) in the samples with detectable antibiotic agent (P<.0001). Conclusions: After topical preoperative administration, moxifloxacin 0.5% ophthalmic solution had a 38-fold to 50-fold higher concentration in the aqueous humor than besifloxacin 0.6% ophthalmic suspension. Besifloxacin was undetectable in more than half the aqueous humor samples. Financial Disclosure: No author has a financial or proprietary interest in any material or method mentioned.
UR - http://www.scopus.com/inward/record.url?scp=77955565566&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77955565566&partnerID=8YFLogxK
U2 - 10.1016/j.jcrs.2010.04.030
DO - 10.1016/j.jcrs.2010.04.030
M3 - Article
C2 - 20692561
AN - SCOPUS:77955565566
SN - 0886-3350
VL - 36
SP - 1499
EP - 1502
JO - Journal of cataract and refractive surgery
JF - Journal of cataract and refractive surgery
IS - 9
ER -